Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Agilent to Host Forensics Webinar

Published: Wednesday, June 05, 2013
Last Updated: Thursday, June 06, 2013
Bookmark and Share
The webinar, which will be held on June 20, will focus on LC/MS/MS methods for cannabinoid and benzodiazepine quantitation in whole blood samples.

The new quantitative methods, designed to run on Agilent’s LC/MS/MS instrumentation, fulfill stringent validation guidelines and provide forensic toxicology laboratories with a complete protocol for the quantitation of two of the most commonly abused drug classes in the United States. This set of Agilent methods is the first in a series now under evaluation by the Virginia Department of Forensic Science. Additional methods will cover 150 commonly abused drugs, spanning more than 10 classes of drugs, including designer drugs, for use in forensic toxicology.

During the webinar, Dr. Rebecca Wagner, research analyst from Virginia’s Department of Forensic Science, will describe the methods and their applications in detail. Attendees will receive electronic access to the complete set of standard operating procedures, detailed validation data, and the LC/MS/MS method to help their laboratories implement the methodology. The webinar will also be available for on-demand replay.

“One of the greatest challenges laboratories face when onboarding new technology is method development and validation,” said Tom Gluodenis, Agilent’s global marketing manager of forensics and toxicology. “That’s why we have collaborated with lab director Linda Jackson and her team at the Virginia Department of Forensic Science to develop a set of standardized LC/MS/MS methods for law enforcement’s most commonly tested drugs. This set of panels will enable forensic toxicology laboratories to obtain immediate, high-quality results with minimal effort.”

“We have developed two separate quantitative methods for the analysis of cannabinoids, benzodiazepines and their metabolites,” said Dr. Wagner. “These standardized methods meet rigorous validation guidelines, including those proposed by the Scientific Working Group for Forensic Toxicology. They take the onus off toxicologists to develop their own quantitative methods, and provide them with thoroughly validated methods for some of their most commonly analyzed compounds.”

“Now, when laboratories purchase Agilent LC/MS/MS instrumentation,” Gluodenis said, “we can provide them with both highly reliable technology and a set of advanced screening solutions that have been validated by one of the nation’s preeminent forensic institutions.”

Method Development

The Virginia Department of Forensic Science analyzes biological specimens for the presence or absence of drugs and alcohol in DUI/DUID, medical examiner, and police cases. Cannabinoids and benzodiazepines are two of the more frequently quantitated drug classes for DUID cases in the Commonwealth of Virginia. In 2012, 2,524 DUID cases were analyzed. Of those cases, 35 percent contained cannabinoids and 31 percent contained benzodiazepines.

Two separate quantitative methods have been developed and validated that include, but are not limited to, the experiments described in the method-validation guidelines proposed by the Scientific Working Group for Forensic Toxicology. The cannabinoid method targets were THC, THC-COOH, THC-OH, cannabinol and cannabidiol. There were 22 target compounds for the benzodiazepine method that included parent compounds and their metabolites. The department’s validation procedures, in conjunction with the proposed SWGTOX guidelines, have facilitated the implementation of a standard method development and validation plan. In the live webinar presentation on June 20, the methods will be described in detail, from initial development to implementation in the four laboratories that comprise the Virginia Department of Forensic Science.

Click below to register for the webinar, “LC/MS/MS Validation of a Cannabinoid and Benzodiazepine Method with Comparison to the Proposed SWGTOX Method Validation Standards.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More Than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Agilent Presents Thought Leader Award to Renowned Medicinal Scientist
Company has announced that Dr. Shilin Chen has received an Agilent Thought Leader Award in support of his groundbreaking herbal genomics research using multi-omics techniques.
Saturday, April 30, 2016
Agilent Technologies Introduces First Commercial Software
Company has introduced new software to help cancer researchers in metabolic flux analysis.
Tuesday, April 19, 2016
Agilent, ASI Announce Agreement
Company has announced co-marketing agreement with ASI for fluorescence in situ hybridization.
Friday, April 08, 2016
Agilent Technologies and Eurofins Genomics Collaborate
Company has announced collaboration with Eurofins Genomics to expand SureVector cloning system.
Tuesday, March 22, 2016
Agilent Technologies to Sponsor USCAP 2016
Company has announced that it will be a Silver sponsor of USCAP 2016, the annual gathering of the United States and Canadian Academy of Pathology.
Thursday, March 10, 2016
Agilent Names CNAG as Certified Provider of Target-Enrichment Services
Centro Nacional de Análisis Genómico (CNAG) in Barcelona is one of Europe’s leading genome analysis centers.
Monday, February 23, 2015
Agilent to Close NMR Business
The announcement is part of Agilent's strategy to address the business shortfalls of its Research Products Division.
Wednesday, October 15, 2014
Agilent Technologies, University of Toronto to Collaborate on Metabolomics MRM Library-Software Solution
Scientists will be provided with a robust LC/MS solution to accelerate cell biology, disease research.
Tuesday, September 30, 2014
Agilent, Seoul National University to Collaborate on New Research Center
The facility will support new drug development center in the university's college of pharmacy.
Tuesday, May 13, 2014
Agilent Introduces Enhanced Electronic Laboratory Notebook
OpenLAB ELN integrates scientific results from multiple analytical software applications, quickly and easily.
Tuesday, November 19, 2013
Agilent and Daegu Gyeongbuk Institute of Science and Technology Collaborate
Neurometabolomics Center will use Agilent's bio-analytical instruments in research of biomarkers for early detection and diagnosis of brain diseases.
Friday, November 01, 2013
Agilent Combines Its Life Sciences and Diagnostics Businesses
Decision follows Agilent's announcement that it plans to separate the company into two independent publicly traded companies.
Thursday, September 19, 2013
Agilent to Acquire Assets from ABC Instrumentación Analítica
The companies have signed a definitive agreement for Agilent to acquire assets from the privately held Mexican distributor.
Thursday, September 05, 2013
Agilent Reports Third-Quarter Results
Revenues were $1.65 billion for the third fiscal quarter ended July 31, 2013, down 4 percent over one year ago.
Thursday, August 15, 2013
Agilent Technologies Triple Quadrupole ICP-MS Selected for R&D 100 Award
These prestigious awards recognize the 100 most technologically significant products introduced into the marketplace over the past year.
Monday, July 15, 2013
Scientific News
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Apricot Kernels Pose Risk of Cyanide Poisoning
Eating more than three small raw apricot kernels, or less than half of one large kernel, in a serving can exceed safe levels. Toddlers consuming even one small apricot kernel risk being over the safe level.
Cell Transplant Treats Parkinson’s in Mice
A University of Wisconsin—Madison neuroscientist has inserted a genetic switch into nerve cells so a patient can alter their activity by taking designer drugs that would not affect any other cell.
Understanding Female HIV Transmission
Glowing virus maps points of entry through entire female reproductive tract for first time.
Genetic Markers Influence Addiction
Differences in vulnerability to cocaine addiction and relapse linked to both inherited traits and epigenetics, U-M researchers find.
Lab-on-a-Chip for Detecting Glucose
By integrating microfluidic chips with fiber optic biosensors, researchers in China are creating ultrasensitive lab-on-a-chip devices to detect glucose levels.
A lncRNA Regulates Repair of DNA Breaks in Breast Cancer Cells
Findings give "new insight" into biology of tough-to-treat breast cancer.
COPD Linked to Increased Bacterial Invasion
Persistent inflammation in COPD may result from a defect in the immune system that allows airway bacteria to invade deeper into the lung.
Detection of HPV in First-Void Urine
Similar sensitivity of HPV test on first void urine sample compared to cervical smear.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!